Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 07, 2016 6:30 AM ET

Capital Markets

Company Overview of Third Rock Ventures, LLC

Company Overview

Third Rock Ventures, LLC is a venture capital firm specializing in start up and early stage investments. The firm primarily invests in life sciences, disruptive science, and healthcare companies with a focus on biotechnology, medical technology, information technology and data, drugs, devices and diagnostics, therapeutics, oncology research, and medical devices. It also focuses on cardiovascular medical devices companies. It prefers to invest in the Boston area. It seeks to make an initial investment of up to $35 million. The firm prefers to lead investing rounds in its portfolio companies and can also collaborate with larger pharmaceutical and biotechnology companies. It seeks an active inv...

29 Newbury Street

3rd Floor

Boston, MA 02116-3135

United States

Founded in 2007





Key Executives for Third Rock Ventures, LLC

Co-Founder and Partner
Age: 65
Co-Founder and Partner
Age: 52
Partner and Co-Founder
Age: 59
Partner and Chief Financial Officer
Manager of Operations and Administration
Compensation as of Fiscal Year 2015.

Third Rock Ventures, LLC Key Developments

Third Rock Ventures, LLC Appoints Michael W. Bonney as New Partner

Michael W. Bonney has been hired as new partner by Third Rock Ventures, LLC with effect from January 7, 2016. Lately, he worked as chief executive officer of Cubist Pharmaceuticals Inc. from June 2003 until December 2014. Before that, he played several leadership roles in successful biotechnology and pharmaceutical firms, including Biogen and Zeneca Pharmaceuticals.

Third Rock Ventures, LLC Appoints Michael W. Bonney as Partner

Third Rock Ventures, LLC announced that Michael W. Bonney is joining the firm as a partner effective January 7, 2016. Most recently, Mr. Bonney served as chief executive officer of Cubist Pharmaceuticals Inc. from June 2003 until December 2014.

Third Rock Ventures, LLC Presents at 14th Annual BIO Investor Forum, Oct-20-2015

Third Rock Ventures, LLC Presents at 14th Annual BIO Investor Forum, Oct-20-2015 . Venue: Parc 55 Hotel, San Francisco, California, United States.

Similar Private Companies By Industry

Company Name Region
The Piper Group, L.L.C. United States
First Capital Investments, LLC United States
Citi Private Bank United States
Cabot Hill Acquisition Corporation United States
Teneo Holdings LLC United States

Recent Private Companies Transactions

Private Placement
December 1, 2015
Constellation Pharmaceuticals, Inc.
Private Placement
October 13, 2015
Decibel Therapeutics, Inc.
Private Placement
September 30, 2015
Neon Therapeutics Inc.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Third Rock Ventures, LLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at